Veracyte (VCYT) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to -$418.8 million.
- Veracyte's Retained Earnings rose 675.07% to -$418.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$418.8 million, marking a year-over-year increase of 675.07%. This contributed to the annual value of -$444.0 million for FY2024, which is 515.64% up from last year.
- Per Veracyte's latest filing, its Retained Earnings stood at -$418.8 million for Q3 2025, which was up 675.07% from -$437.9 million recorded in Q2 2025.
- Veracyte's 5-year Retained Earnings high stood at -$323.5 million for Q1 2021, and its period low was -$470.0 million during Q1 2024.
- For the 5-year period, Veracyte's Retained Earnings averaged around -$407.2 million, with its median value being -$410.2 million (2023).
- As far as peak fluctuations go, Veracyte's Retained Earnings plummeted by 2683.4% in 2021, and later soared by 703.19% in 2025.
- Quarter analysis of 5 years shows Veracyte's Retained Earnings stood at -$357.2 million in 2021, then dropped by 10.24% to -$393.7 million in 2022, then fell by 18.9% to -$468.1 million in 2023, then grew by 5.16% to -$444.0 million in 2024, then increased by 5.68% to -$418.8 million in 2025.
- Its Retained Earnings was -$418.8 million in Q3 2025, compared to -$437.9 million in Q2 2025 and -$436.9 million in Q1 2025.